Clarity Pharmaceuticals Ltd (ASX:CU6)
3.800
-0.580 (-13.24%)
Aug 8, 2025, 4:10 PM AEST
Verve Therapeutics Revenue
Clarity Pharmaceuticals had revenue of 4.69M AUD in the half year ending December 31, 2024, a decrease of -18.22%. This brings the company's revenue in the last twelve months to 10.78M, up 13.61% year-over-year. In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M with 17.41% growth.
Revenue (ttm)
10.78M
Revenue Growth
+13.61%
P/S Ratio
151.16
Revenue / Employee
215.54K
Employees
50
Market Cap
1.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 11.51M | 1.71M | 17.41% |
Jun 30, 2023 | 9.80M | 3.34M | 51.74% |
Jun 30, 2022 | 6.46M | 3.26M | 102.06% |
Jun 30, 2021 | 3.20M | 407.65K | 14.62% |
Jun 30, 2020 | 2.79M | 145.32K | 5.50% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |
Clarity Pharmaceuticals News
- 3 days ago - Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance - The Australian Financial Review
- 11 days ago - Clarity Pharmaceuticals readies mega capital raising - The Australian Financial Review
- 8 months ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
- 8 months ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
- 10 months ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
- 1 year ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review